Virginia Endocrinology Midlothian, VA - 23112

Virginia Endocrinology is categorized under Endocrinologists in Midlothian, VA .

Virginia Endocrinology was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Shari Moyers, Office Manager at the company’s single location by writing to 2384 Colony Crossing Place, Midlothian, Virginia VA 23112 or by phoning (804) 423-3636. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Virginia Endocrinology
Contact Person: Shari Moyers, Office Manager
Address: 2384 Colony Crossing Place, Midlothian, Virginia 23112
Phone Number: (804) 423-3636
Website Address: virginiaendo.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Endocrinologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Virginia Endocrinology was started in 0 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Shari Moyers, Office Manager for inquiries that concern Virginia Endocrinology by calling the company number (804) 423-3636, as your correspondence is most welcome. Additionally, the physical location of the single location of Virginia Endocrinology can be found at the coordinates 37.45852,-77.6558 as well as the street address 2384 Colony Crossing Place in Midlothian, Virginia 23112.

For its online presence, you may visit Virginia Endocrinology’s website at virginiaendo.com and engage with its social media outlets through on Twitter and on Facebook.